From October 4-6 Lunteren was the place to share knowledge, discuss science and the future of regulatory affaires and see over 50 Top Institute Pharma researchers present their work at the Figon Dutch Medicines Days 2010.

We actively participated in this unique event. Highlights were our annual Top Institute Pharma lecture by Thomas Lönngren about the future of regulatory affairs and the session “Drug selectivity; Necessity or not”. This session was about the dominant paradigm in drug discovery to design maximally selective ligands to act on a single target.

For more information, please visit www.figondmd2010.nl